Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the Academic Research Consortium for High …
Identification and management of patients at high bleeding risk undergoing percutaneous
coronary intervention are of major importance, but a lack of standardization in defining this …
coronary intervention are of major importance, but a lack of standardization in defining this …
Risk and management of bleeding complications with direct oral anticoagulants in patients with atrial fibrillation and venous thromboembolism: a narrative review
S Ballestri, E Romagnoli, D Arioli, V Coluccio… - Advances in …, 2023 - Springer
Atrial fibrillation (AF) and venous thromboembolism (VTE) are highly prevalent conditions
with a significant healthcare burden, and represent the main indications for anticoagulation …
with a significant healthcare burden, and represent the main indications for anticoagulation …
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind …
Background Direct-acting oral anticoagulant use for stroke prevention in atrial fibrillation is
limited by bleeding concerns. Asundexian, a novel, oral small molecule activated …
limited by bleeding concerns. Asundexian, a novel, oral small molecule activated …
Association of oral anticoagulants and proton pump inhibitor cotherapy with hospitalization for upper gastrointestinal tract bleeding
Importance Anticoagulant choice and proton pump inhibitor (PPI) cotherapy could affect the
risk of upper gastrointestinal tract bleeding, a frequent and potentially serious complication …
risk of upper gastrointestinal tract bleeding, a frequent and potentially serious complication …
Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants: A nationwide propensity score–weighted study
Background: Gastrointestinal bleeding (GIB) rates for direct oral anticoagulants (DOACs)
and warfarin have been extensively compared. However, population-based studies …
and warfarin have been extensively compared. However, population-based studies …
Long-term comparative effectiveness and safety of dabigatran, rivaroxaban, apixaban and edoxaban in patients with atrial fibrillation: A nationwide cohort study
M Grymonprez, TL De Backer, X Bertels… - Frontiers in …, 2023 - frontiersin.org
Background: Although non-vitamin K antagonist oral anticoagulants (NOACs) are
recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management …
recommended over vitamin K antagonists (VKAs) in atrial fibrillation (AF) management …
Effectiveness and safety of apixaban compared with rivaroxaban for patients with atrial fibrillation in routine practice: a cohort study
M Fralick, M Colacci, S Schneeweiss… - Annals of internal …, 2020 - acpjournals.org
Background: Apixaban and rivaroxaban are the most commonly prescribed direct oral
anticoagulants for adults with atrial fibrillation, but head-to-head data comparing their safety …
anticoagulants for adults with atrial fibrillation, but head-to-head data comparing their safety …
Drug-drug interactions with direct oral anticoagulants associated with adverse events in the real world: a systematic review
Abstract Background Direct oral anticoagulants (DOACs) have emerged as safe and
effective alternatives to Vitamin-K antagonists for treatment and prevention of arterial and …
effective alternatives to Vitamin-K antagonists for treatment and prevention of arterial and …
[PDF][PDF] Low-dose warfarin may be a life-saving treatment regimen in sickle cell diseases
MR Helvaci, A Vural, K Onay, A Abyad, L Pocock - World Family Med, 2023 - mejfm.com
Abstract Background: Sickle cell diseases (SCDs) are inborn and destructive processes on
vascular endothelium, particularly at the capillaries. Methods: All patients with the SCDs …
vascular endothelium, particularly at the capillaries. Methods: All patients with the SCDs …
Atrial fibrillation and oral anticoagulation in older people with frailty: a nationwide primary care electronic health records cohort study
Background Atrial fibrillation (AF) is common in older people and is associated with
increased stroke risk that may be reduced by oral anticoagulation (OAC). Frailty also …
increased stroke risk that may be reduced by oral anticoagulation (OAC). Frailty also …